skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families

Journal Article · · American Journal of Human Genetics; (United States)
OSTI ID:6333480
;  [1]; ;  [2]
  1. Cancer Research Campaign and Inst. of Cancer Research, Surrey (United Kingdom)
  2. St. James's Hospital, Leeds (United Kingdom)

This paper reports the results of a collaborative linkage study involving 214 breast cancer families, including 57 breast-ovarian cancer families; this represents almost all the known families with 17q linkage data. Six markers on 17q, spanning approximately 30 cM, were typed in the families. The aims of the study were to define more precisely the localization of the disease gene, the extent of genetic heterogeneity and the characteristics of linked families and to estimate the penetrance of the 17q gene. Under the assumption of no genetic heterogeneity, the strongest linkage evidence was obtained with D17S588. Multipoint linkage analysis allowing for genetic heterogeneity provided evidence that the predisposing gene lies between the markers D17S588 and D17S250, an interval whose genetic length is estimated to be 8.3 cM in males and 18.0 cM in females. This position was supported over other intervals by odds of 66:1. The location of the gene with respect to D17S579 could not be determined unequivocally. Under the genetic model used in the analysis, the best estimate of the proportion of linked breast-ovarian cancer families was 1.0 (lower LOD -- 1 limit 0.79). In contrast, there was significant evidence of genetic heterogeneity among the families without ovarian cancer, with an estimated 45% being linked. These results suggest that a gene(s) on chromosome 17q accounts for the majority of families in which both early-onset breast cancer and ovarian cancer occur but that other genes predisposing to breast cancer exist. By examining the fit of the linkage data to different penetrance functions, the cumulative risk associated with the 17q gene was estimated to be 59% by age 50 years and 82% by age 70 years. The corresponding estimates for the breast-ovary families were 67% and 76%, and those for the families without ovarian cancer were 49% and 90%; these penetrance functions did not differ significantly from one another. 42 refs., 5 figs., 2 tabs.

OSTI ID:
6333480
Journal Information:
American Journal of Human Genetics; (United States), Vol. 52:4; ISSN 0002-9297
Country of Publication:
United States
Language:
English

Similar Records

Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21
Journal Article · Thu Apr 01 00:00:00 EST 1993 · American Journal of Human Genetics; (United States) · OSTI ID:6333480

BRCA1-linked marker in postmenopausal breast cancer families
Journal Article · Thu Sep 01 00:00:00 EDT 1994 · American Journal of Human Genetics · OSTI ID:6333480

Linkage studies with 17q and 18q markers in a breast/ovarian cancer family
Journal Article · Thu Apr 01 00:00:00 EST 1993 · American Journal of Human Genetics; (United States) · OSTI ID:6333480